• Mar 14, 2025

3 Reasons to Sell MCRI and 1 Stock to Buy Instead

Monarch currently trades at $84.46 and has been a dream stock for shareholders. It’s returned 388% since March 2020, nearly tripling the S&P 500’s 132% gain. The company has also beaten the index over the past six months as its stock price is up 12.6% thanks to its solid quarterly results.

  • Mar 14, 2025

3 Reasons MANH is Risky and 1 Stock to Buy Instead

Manhattan Associates’s stock price has taken a beating over the past six months, shedding 39.3% of its value and falling to $164.02 per share. This was partly driven by its softer quarterly results and might have investors contemplating their next move.

  • Mar 14, 2025

Q4 Rundown: RTX (NYSE:RTX) Vs Other Defense Contractors Stocks

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how RTX (NYSE:RTX) and the rest of the defense contractors stocks fared in Q4.

  • Mar 14, 2025

3 Reasons to Sell PBI and 1 Stock to Buy Instead

While the broader market has struggled with the S&P 500 down 1.3% since September 2024, Pitney Bowes has surged ahead as its stock price has climbed by 39.6% to $9.27 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.